The manufacturer recalled more than 670,000 cans of Nutramigen infant formula after a finished product sampled outside the US tested positive for Cronobacter.
Mead Johnson is facing a $5m lawsuit from a mother who alleges its infant formula brand, Enfamil, was contaminated by insects leading to the hospitalization of her baby.
Reckitt Benckiser Group plc (RB) has signed a merger agreement with Mead Johnson Nutrition Company (Mead Johnson) under which Mead Johnson shareholders will receive $90 in cash for each share of common stock, valuing the total equity at $16.6bn.
The UK Advertising Standards Authority (ASA) has dismissed a complaint that challenged claims made in a Mead Johnson Nutrition advert on cow's milk allergy in infants.
Mead Johnson Nutrition plans to boost its US infant formula manufacturing capabilities to supply the e-commerce channels opening up between the US and China.
Mead Johnson Nutrition is still waiting for the outcome of a US Securities and Exchange Commission (SEC) probe that could see it penalized on home soil for alleged promotional payments made by employees in China.
Mead Johnson Nutrition has revealed that the US Securities and Exchange Commission (SEC) is probing “certain expenditures” relating to the promotion of infant formula products by its business in China.
Mead Johnson Nutrition is standing by its 2013 full-year forecast, despite recently slashing its infant formula prices in China by up to 15% in the midst of a government anti-trust probe.
A committee of MEPs has voted narrowly in favour of blocking an EFSA-approved health claim that the fatty acid DHA in baby milk is beneficial to children’s eyes.
